Antibiotics No Help Following Gallbladder Surgery
By HospiMedica International staff writers Posted on 23 Jul 2014 |
A new study reveals that prescribing postoperative amoxicillin plus clavulanic acid (ACA) after cholecystectomy does not reduce the risk of infection.
Researchers at CHU Nord (Amiens, France), the University of Picardie (Amiens, France), and other institutions conducted a randomized clinical trial involving 414 patients treated for calculous cholecystitis at 17 medical centers between May 2010 and August 2012, and who received no treatment or 2 grams of ACA (3 times a day for 5 days) following surgery. The main outcome measure was the proportion of postoperative surgical site infections (SSIs) or distant infections recorded before or at the 4-week follow-up visit.
The results showed that all told, there were 66 postoperative infections, including 35 in the nontreatment group and 31 in the antibiotic group. Intent to treat analysis showed that the rates were 17% in the nontreatment group and 15% in the ACA antibiotic group. A per-protocol analysis involving 338 patients saw infection rates of 13% in both arms. In all, the researchers concluded that the infection rate after cholecystectomy was virtually identical with and without postoperative ACA. The study was published in the July 9, 2014, issue of the Journal of the American Medical Association (JAMA).
“Among patients with mild or moderate calculous cholecystitis who received preoperative and intraoperative antibiotics, lack of postoperative treatment with amoxicillin plus clavulanic acid did not result in a greater incidence of postoperative infections,” concluded lead author Jean-Marc Regimbeau, MD, PhD, and colleagues, cautioning that “the absence of placebo in the nontreatment arm and the lack of blinding might have decreased the reliability of our evaluation of the primary outcome and the groups’ comparability.”
The combination of Amoxicillin trihydrate (a β-lactam antibiotic) and clavulanic acid (potassium clavulanate, a β-lactamase inhibitor) results in an antibiotic with an increased spectrum of action and restored efficacy against amoxicillin-resistant bacteria that produce β-lactamase. Trade names include Augmentin (by GlaxoSmithKline), Clavamox (by Pfizer), Tyclav (by Beximco Pharma), and many others. Rarely, cholestatic jaundice, a form of liver toxicity, has been associated with ACA. The reaction may occur up to several weeks after treatment has stopped, and usually takes weeks to resolve.
Related Links:
CHU Nord
University of Picardie
Researchers at CHU Nord (Amiens, France), the University of Picardie (Amiens, France), and other institutions conducted a randomized clinical trial involving 414 patients treated for calculous cholecystitis at 17 medical centers between May 2010 and August 2012, and who received no treatment or 2 grams of ACA (3 times a day for 5 days) following surgery. The main outcome measure was the proportion of postoperative surgical site infections (SSIs) or distant infections recorded before or at the 4-week follow-up visit.
The results showed that all told, there were 66 postoperative infections, including 35 in the nontreatment group and 31 in the antibiotic group. Intent to treat analysis showed that the rates were 17% in the nontreatment group and 15% in the ACA antibiotic group. A per-protocol analysis involving 338 patients saw infection rates of 13% in both arms. In all, the researchers concluded that the infection rate after cholecystectomy was virtually identical with and without postoperative ACA. The study was published in the July 9, 2014, issue of the Journal of the American Medical Association (JAMA).
“Among patients with mild or moderate calculous cholecystitis who received preoperative and intraoperative antibiotics, lack of postoperative treatment with amoxicillin plus clavulanic acid did not result in a greater incidence of postoperative infections,” concluded lead author Jean-Marc Regimbeau, MD, PhD, and colleagues, cautioning that “the absence of placebo in the nontreatment arm and the lack of blinding might have decreased the reliability of our evaluation of the primary outcome and the groups’ comparability.”
The combination of Amoxicillin trihydrate (a β-lactam antibiotic) and clavulanic acid (potassium clavulanate, a β-lactamase inhibitor) results in an antibiotic with an increased spectrum of action and restored efficacy against amoxicillin-resistant bacteria that produce β-lactamase. Trade names include Augmentin (by GlaxoSmithKline), Clavamox (by Pfizer), Tyclav (by Beximco Pharma), and many others. Rarely, cholestatic jaundice, a form of liver toxicity, has been associated with ACA. The reaction may occur up to several weeks after treatment has stopped, and usually takes weeks to resolve.
Related Links:
CHU Nord
University of Picardie
Latest Surgical Techniques News
- Miniaturized Snake-Like Probe Images Cerebral Arteries From Within
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing